MedTrace Logo

Chatbot-Assisted Advance Care Planning Education for Family Members

NCT07448649 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-03-04

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a messaging and chatbot program, called ChatACP, helps family members of people living in nursing homes take part in advance care planning.

The main questions this study aims to answer are:

* Does ChatACP help family members feel more ready to talk about future medical and personal care with their loved one?
* Does ChatACP help family members take part in advance care planning activities, such as having care discussions or completing planning documents?
* Is ChatACP easy to use and acceptable for family members?

Researchers will compare ChatACP to standard self-learning materials about advance care planning to see which approach works better.

Participants will:

* Receive short daily messages with pictures or videos about advance care planning and access to a chatbot specialized in ACP for 10 days
* Complete surveys at the start of the study, after the program ends, and again 3 months later
* Take part in an interview to share their experience with the program

Conditions

  • Advance Care Planning

Interventions

BEHAVIORAL

ChatACP - Messaging- and-Chatbot Assisted Nursing Consultation

The ChatACP for family members encompassed a digital education component and a care provider engagement component. The digital education component includes 10-day messages of ACP infographics, video clips, and a chatbot with specific content for ACP. The care provider engagement component includes one nurse-led telephone consultation.

BEHAVIORAL

ACP self- learning handout (Hong Kong Hospital Authority ACP education material)

Participants in the control group will be provided with self-learning ACP education material created by the Hong Kong Hospital Authority for public education.

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2028-06-30
Completion
2028-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07448649 on ClinicalTrials.gov